01/04/2026
Your patient’s hearing threshold isn’t a measure of how they’re performing in the various sound environments of activities in daily living ❌
Therefore, you need to focus both on the quantity of hearing (hearing threshold) and the quality of hearing (hearing-in-noise ability).
A test that sets the Equinox Evo apart* from other clinical audiometers is its ability to perform the award-winning Audible Contrast Threshold (ACT™) test, which predicts hearing-in-noise ability using modulated noise signals.
Because it doesn’t use speech material, it doesn’t matter which language the patient speaks.
This allows you to measure hearing-in-noise ability regardless of your patient’s language ability.
Learn more about the Equinox Evo and discover how it could cover your clinical needs 👉 https://www.interacoustics.com/audiometers/equinox-evo?utm_source=social&utm_medium=facebook&utm_campaign=cenu_evo_blog
*ACT is also available with the Affinity Compact and Callisto™ devices from Interacoustics.